1 study found for:    ACNS1021
Show Display Options
Rank Status Study
1 Completed
Has Results
Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
Conditions: Childhood Cerebellar Anaplastic Astrocytoma;   Childhood Cerebral Anaplastic Astrocytoma;   Childhood Cerebral Astrocytoma;   Childhood Infratentorial Ependymoma;   Childhood Mixed Glioma;   Childhood Oligodendroglioma;   Childhood Supratentorial Ependymoma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma
Interventions: Other: Diagnostic Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Sunitinib Malate

Indicates status has not been verified in more than two years